2022
Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment
Fayanju O, Oyekunle T, Thomas S, Ingraham K, Fish L, Greenup R, Oeffinger K, Zafar S, Hyslop T, Hwang E, Patierno S, Barrett N. Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. The American Journal Of Surgery 2022, 225: 617-629. PMID: 36411107, PMCID: PMC10085670, DOI: 10.1016/j.amjsurg.2022.10.059.Peer-Reviewed Original ResearchMeSH KeywordsColorectal NeoplasmsEarly Detection of CancerHumansMaleMass ScreeningNorth CarolinaPatient Reported Outcome MeasuresSurveys and QuestionnairesConceptsColorectal cancer screeningModifiable factorsCancer screeningGuideline-concordant screeningPatient-reported factorsHealthy dietary habitsHealth assessmentCommunity-based sampleColorectal screeningColorectal cancerDietary habitsDisease preventionMedical careBehavioral interventionsLess breastBreastLifestyle choicesCentral North CarolinaProstateCancerScreeningCommunity eventsGreater knowledgeFactorsNegative attitudes
2017
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer
Gamble C, Havrilesky L, Myers E, Chino J, Hollenbeck S, Plichta J, Kelly Marcom P, Shelley Hwang E, Kauff N, Greenup R. Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer. Annals Of Surgical Oncology 2017, 24: 3116-3123. PMID: 28699130, PMCID: PMC5990891, DOI: 10.1245/s10434-017-5995-z.Peer-Reviewed Original ResearchConceptsRisk-reducing mastectomyOvarian cancer diagnosisIncremental cost-effectiveness ratioBRCA mutation carriersMonths of lifeMutation carriersMagnetic resonance imagingCancer diagnosisSurvival benefitOvarian cancerMutation statusMost BRCA1/2 mutation carriersThird-party payer perspectiveGreater survival benefitBreast cancer riskBRCA mutation statusBRCA1/2 mutation carriersBRCA2 mutation carriersBRCA2 mutation statusBRCA1 mutation carriersBreast cancer screeningMonte Carlo probabilistic sensitivity analysisCost-effectiveness ratioYears of lifeProbabilistic sensitivity analyses